Based on published literature implicating transcription factor ETS-1 as an activator of ICAM1 gene transcription (10–13), we considered it a promising drug target for blocking the induction of ICAM-1 during non-infectious posterior uveitis. Here, ICAM1 is linked to posterior uveitis.